Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 53002-1547 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
topi - ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 01
Topi - ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 02
This appears to be a chart displaying cumulative rates for time to first seizure for two groups of individuals taking different dosages of topiramate. The x-axis (horizontal) represents time in days and the y-axis (vertical) represents the cumulative percentage of individuals who had not yet experienced a seizure. The two groups are distinguished by different colored lines and the number of individuals in each group is provided in parentheses next to the drug dosage.*
Figure 2: Reduction in 4-Week Migraine Headache Frequency(Studies 10 and 11 for Adults and Adolescents) - ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 03
The text describes the change from baseline in the average monthly migraine period rate for the double-blind phase of a study involving Topamax at doses of 100 and 200 mg/day. There is a significant reduction in migraine period rate with Topamax, as demonstrated by a statistical analysis showing p-values of less than 0.001 and 0.0001.*
Label Image - lbl530021547
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.